Results 41 to 50 of about 31,411 (361)

On-line signature verification using Tablet PC [PDF]

open access: yes, 2022
On-line signature verification for Tablet PC devices is studied. The on-line signature verification algorithm presented by the authors at the First International Signature Verification Competition (SVC 2004) is adapted to work in Tablet PC environments.
arxiv   +1 more source

Design, development and in-vitro evaluation of pinaverium colon targeted tablets [PDF]

open access: yes, 2020
In the present research work colon formulation of Pinaverium targeted to colon by using various polymers developed. To achieve pH-independent drug release of Pinaverium, pH modifying agents (buffering agents) were used.
M. Neharika, Shaik Harun Rasheed
core   +3 more sources

Terahertz Frequency-Domain Sensing Combined with Quantitative Multivariate Analysis for Pharmaceutical Tablet Inspection [PDF]

open access: yes, 2022
Near infrared (NIR) and Raman spectroscopy combined with multivariate analysis are established techniques for the identification and quantification of chemical properties of pharmaceutical tablets like the concentration of active pharmaceutical ingredients (API).
arxiv   +1 more source

Evolution of a physiological pH 6.8 bicarbonate buffer system: application to the dissolution testing of enteric coated products. [PDF]

open access: yes, 2011
The use of compendial pH 6.8 phosphate buffer to assess dissolution of enteric coated products gives rise to poor in vitro-in vivo correlations because of the inadequacy of the buffer to resemble small intestinal fluids.
Abdul W. Basit   +44 more
core   +1 more source

Optimasi Formula Tablet Salut Enterik Natrium Diklofenak dengan Bahan Penyalut Kollicoat 30 D [PDF]

open access: yes, 2014
Diclofenac sodium is an analgetic and antiinflammation drug and commonly used by oral administration. Because of it’s side effects that can cause stomach irritation, nausea and vomiting, it’s made in the form of enteric-coated.
Yunarto, Nanang
core   +2 more sources

Preformulation and preliminary formulation studies of mesalazine gastro-resistant tablets [PDF]

open access: yesRomanian Journal of Pharmaceutical Practice, 2020
Mesalamine, 5-aminosalicylic acid or mesalazine is the standard therapy of inflammatory bowel disease. A small number of pharmaceutical dosage forms with mesalazine are on the market.
Adriana Aurelia Chiş   +5 more
doaj   +1 more source

Simulating strange attraction of acellular slime mould Physarum polycephaum to herbal tablets [PDF]

open access: yesMathematical and Computer Modelling 55(3-4): 884-900 (2012), 2012
Plasmodium of acellular slime mould Physarum polycephalum exhibits traits of wave-like behaviour. The plasmodium's behaviour can be finely tuned in laboratory experiments by using herbal tablets. A single tablet acts as a fixed attractor: plasmodium propagates towards the tablet, envelops the tablet with its body and stays around the tablet for several
arxiv   +1 more source

Development of a multiparticulate system containing enteric-release mini-tablets of omeprazole

open access: yesBrazilian Journal of Pharmaceutical Sciences, 2014
The main aim of this study was to develop a multiparticulate system containing mini-tablets of omeprazole formulated with an enteric polymer with pH-dependent solubility.
Volnei Jose Tondo Filho   +3 more
doaj   +1 more source

In Vitro Evaluation of Eslicarbazepine Delivery via Enteral Feeding Tubes [PDF]

open access: yes, 2017
Purpose: The feasibility of preparing an eslicarbazepine acetate suspension using Aptiom tablets for administration via enteral feeding tubes was evaluated.
Dave, Vivek S   +3 more
core   +2 more sources

A Case of Neuropsychiatric Systemic Lupus Erythematosus With Hair Loss as the First Diagnostic Symptom

open access: yesFrontiers in Psychiatry, 2022
Neuropsychiatric systemic lupus erythematosus is a serious complication of systemic lupus erythematosus. A 33-year-old female patient had repeated hair loss for more than 3 years.
Xun He, Xi-Ling Duan, Jing-Song Liu
doaj   +1 more source

Home - About - Disclaimer - Privacy